In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which immunotherapeutics...
The U.S. Latino population surged 243 percent from 1980 to 2010. But in the same time span, the Latino...
After several previous attempts to repeal the Affordable Care Act (ACA) failed, another attempt is nearing a vote in...
The AACR is holding a special conference, Advances in Modeling Cancer in Mice: Technology, Biology, and Beyond, in Orlando,...
The flurry of treatments approved by the U.S. Food and Drug Administration (FDA) for treating hematological malignancies continued last...
Today, the American Association for Cancer Research (AACR) released its seventh annual Cancer Progress Report. The report highlights how...
When runners cross the starting line at the AACR Rock ‘n’ Roll Philadelphia races later this month, several will...
This week, some of the world’s leading cancer researchers are gathering in Mainz/Frankfurt, Germany for the Third International Cancer...
This week’s excitement surrounding the groundbreaking U.S. Food and Drug Administration (FDA) approval of the CAR T–cell therapy tisagenlecleucel...
Yesterday marked a much anticipated milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced the...